Literature DB >> 17963303

Plasma and platelet serotonin levels in patients with liver cirrhosis.

Dorde M Culafic1, Dusko S Mirkovic, Miodrag D Vukcevic, Jelena S Rudic.   

Abstract

AIM: To analyze the relationship between plasma and platelet serotonin levels and the degree of liver insufficiency.
METHODS: The prospective study included 30 patients with liver cirrhosis and 30 healthy controls. The degree of liver failure was assessed according to the Child-Pugh classification. Platelet and platelet poor plasma serotonin levels were determined.
RESULTS: The mean plasma serotonin level was higher in liver cirrhosis patients than in healthy subjects (215.0 +/- 26.1 vs 63.1 +/- 18.1 nmol/L; P < 0.0001). The mean platelet serotonin content was not significantly different in patients with liver cirrhosis compared with healthy individuals (4.8 +/- 0.6; 4.2 +/- 0.3 nmol/platelet; P > 0.05). Plasma serotonin levels were significantly higher in Child-Pugh grade A/B than in grade C patients (246.8 +/- 35.0 vs 132.3 +/- 30.7 nmol/L; P < 0.05). However, platelet serotonin content was not significantly different between Child-Pugh grade C and grade A/B (4.6 +/- 0.7 vs 5.2 +/- 0.8 nmol/platelet; P > 0.05).
CONCLUSION: Plasma serotonin levels are significantly higher in patients with cirrhosis than in the controls and represent the degree of liver insufficiency. In addition, platelet poor plasma serotonin estimation is a better marker for liver insufficiency than platelet serotonin content.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17963303      PMCID: PMC4171263          DOI: 10.3748/wjg.v13.i43.5750

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  16 in total

1.  Platelet serotonin (5-HT) content is decreased in patients with alcoholic liver cirrhosis, but elevated in Gilbert's syndrome.

Authors:  D Borcsiczky; F Szalay; K Tekes; J Tarcali; K Magyar; R de Châtel
Journal:  J Hepatol       Date:  1996-11       Impact factor: 25.083

Review 2.  The measurement of 5-hydroxyindoleacetic acid in urine.

Authors:  A C Deacon
Journal:  Ann Clin Biochem       Date:  1994-05       Impact factor: 2.057

3.  Definition of an uptake pharmacophore of the serotonin transporter through 3D-QSAR analysis.

Authors:  J Pratuangdejkul; B Schneider; P Jaudon; V Rosilio; E Baudoin; S Loric; M Conti; J-M Launay; P Manivet
Journal:  Curr Med Chem       Date:  2005       Impact factor: 4.530

4.  Platelet and plasma serotonin in patients with liver cirrhosis.

Authors:  B Marasini; M L Biondi; A Agostoni
Journal:  J Clin Chem Clin Biochem       Date:  1989-07

5.  Increased activities of MAOA and MAOB in autopsied brain tissue from cirrhotic patients with hepatic encephalopathy.

Authors:  V L Rao; J F Giguère; G P Layrargues; R F Butterworth
Journal:  Brain Res       Date:  1993-09-10       Impact factor: 3.252

6.  Effects of serotonin on platelet activation in whole blood.

Authors:  N Li; N H Wallén; M Ladjevardi; P Hjemdahl
Journal:  Blood Coagul Fibrinolysis       Date:  1997-11       Impact factor: 1.276

Review 7.  Coagulation disorders in liver disease.

Authors:  Lucio Amitrano; Maria A Guardascione; Vincenzo Brancaccio; Antonio Balzano
Journal:  Semin Liver Dis       Date:  2002-02       Impact factor: 6.115

8.  Pulmonary arterial hypertension and type-I glycogen-storage disease: the serotonin hypothesis.

Authors:  M Humbert; P Labrune; O Sitbon; C Le Gall; J Callebert; P Hervé; D Samuel; R Machado; R Trembath; L Drouet; J M Launay; G Simonneau
Journal:  Eur Respir J       Date:  2002-07       Impact factor: 16.671

9.  Platelet serotonin and plasma tryptophan decreases in endogenous depression. Clinical, therapeutic, and biological correlations.

Authors:  J Quintana
Journal:  J Affect Disord       Date:  1992-02       Impact factor: 4.839

10.  Increased plasma serotonin in primary pulmonary hypertension.

Authors:  P Hervé; J M Launay; M L Scrobohaci; F Brenot; G Simonneau; P Petitpretz; P Poubeau; J Cerrina; P Duroux; L Drouet
Journal:  Am J Med       Date:  1995-09       Impact factor: 4.965

View more
  4 in total

1.  Role of serotonin in development of esophageal and gastric fundal varices.

Authors:  Jelena S Rudić; Dorđe M Culafić; Duško S Mirković; Rada S Ješić; Miodrag N Krstić
Journal:  World J Gastroenterol       Date:  2010-12-28       Impact factor: 5.742

2.  Switching-on of serotonergic calcium signaling in activated hepatic stellate cells.

Authors:  Kyu-Sang Park; Pyo-Jin Sin; Dong Hyeon Lee; Seung-Kuy Cha; Min-Jeong Kim; Na-Hyun Kim; Soon-Koo Baik; Seong-Woo Jeong; In Deok Kong
Journal:  World J Gastroenterol       Date:  2011-01-14       Impact factor: 5.742

3.  Modulation of vascular contraction via soluble guanylate cyclase signaling in a novel ex vivo method using rat precision-cut liver slices.

Authors:  Anouk Oldenburger; Gerald Birk; Marco Schlepütz; Andre Broermann; Birgit Stierstorfer; Steven S Pullen; Jörg F Rippmann
Journal:  Pharmacol Res Perspect       Date:  2021-05

4.  Risk of depressive disorder following non-alcoholic cirrhosis: a nationwide population-based study.

Authors:  Chin-Lin Perng; Cheng-Che Shen; Li-Yu Hu; Chiu-Mei Yeh; Mu-Hong Chen; Chia-Fen Tsai; Huey-Ling Chiang; Yi-Ping Hung; Vincent Yi-Fong Su; Yu-Wen Hu; Tung-Ping Su; Pan-Ming Chen; Jeng-Hsiu Hung; Chia-Jen Liu; Min-Wei Huang
Journal:  PLoS One       Date:  2014-02-12       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.